Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent

Ayoub, BM; Mowaka, S; Safar, MM; Ashoush, N; Arafa, MG; Michel, HE; Tadros, MM; Elmazar, MM; Mousa, SA

Ayoub, BM (reprint author), British Univ Egypt, Dept Pharmaceut Chem, Fac Pharm, Cairo, Egypt.; Ayoub, BM (reprint author), British Univ Egypt, CDRD, Fac Pharm, Cairo, Egypt.

SCIENTIFIC REPORTS, 2018; 8 ():

Abstract

Drug repositioning is a revolution breakthrough of drug discovery that presents outstanding privilege with already safer agents by scanning the existi......

Full Text Link